Falling vaccination rates in the US prompted a guidance downgrade at CSL, but was the market's reaction excessive?

Brian McNamee, the man who transformed CSL from a sleepy government department to one of Australia’s largest companies, has ...

Better times ahead? The post Expert sees 34% upside potential for CSL shares despite ongoing challenges appeared first on The ...

SYDNEY--Shares in Australia-based pharmaceutical company CSL tumbled 15% on Tuesday after the company delayed the spinoff of its flu vaccine unit and cut annual guidance. In late morning trade Tuesday ...

CSL Ltd (ASX: CSL) shares are having another day to forget on Tuesday. Let's see why investors are selling its ...

CSL plunged lower this morning following the headlines that the company had scrapped plans to complete a demerger of its ...

CSL’s head of investor relations, Chris Cooper, is understood to be leaving the Australian healthcare group as the $87bn blue ...

A slump in two major stocks and investors awaiting crucial economic data led to a fall on the local market during Tuesday’s ...

Heavy falls in the healthcare and tech sectors are dragging the Aussie bourse lower, despite seven of the 11 sectors moving ...

CSL shareholders have revolted against Australia’s largest pharmaceutical company, giving it a second strike in as many years ...

The Australian sharemarket finished in the red on Tuesday, with steep falls in gold miners and some big companies outweighing ...